PDFsegment Information [45.0KB]

(billion yen)

FYE 3/'19FYE 3/'20FYE 3/'21
(guidance)
Cardiac and Vascular Company328.5350.6319.0
General Hospital Company165.8171.0173.0
Blood and Cell Technologies Company105.0107.2108.0
Adjustments0.20.2-
Total599.5628.9600.0

※Terumo Corporation has adopted IFRS from the fiscal year ended March 31, 2018.

Revenue by Business Segment

Cardiac and Vascular Company

General Hospital Company

Blood and Cell Technologies Company